RNS Number : 0752G
Ananda Developments PLC
30 September 2024
 

30 September 2024

 

Ananda Developments plc

 

("Ananda Developments" or the "Company")

 

Total Voting Rights

 

In accordance with the Financial Conduct Authority's Disclosure and Transparency Rules, Ananda announces that the Company has 3,619,980,106 ordinary shares of 0.2p each in issue ("Ordinary Shares"), each share carrying the right to one vote.


This figure of 3,619,980,106 Ordinary Shares may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.

 

To stay up to date with the latest developments at Ananda, we encourage you to follow and join our social media channels which are:  

  

·      Register at our Investor Hub: https://investors.anandadevelopments.com/s/a66906

·      Instagram: https://instagram.com/anandadevelopments?igshid=YmMyMTA2M2Y=   

·      LinkedIn: https://www.linkedin.com/company/anadevelopments/   

·      Twitter: https://twitter.com/AnandaPlc

·      Investor Meet Company: https://www.investormeetcompany.com/ananda-developments-plc/register-investor

 

-Ends-

The Directors of the Company accept responsibility for the contents of this announcement.

InvestorHub

Engage with us directly at Ananda Developments Investor Hub

 

Sign up at https://investors.anandadevelopments.com/s/a66906

 

ANANDA DEVELOPMENTS PLC

Chief Executive Officer

Melissa Sturgess


Finance Director

Jeremy Sturgess-Smith

 

+44 (0)7463 686 497 ir@anandadevelopments.com

SP ANGEL CORPORATE FINANCE LLP

Corporate Finance

Richard Morrison

Caroline Rowe

+44 (0)20 3470 0470

Corporate Broking

Abigail Wayne

Rob Rees

 


Yellow Jersey PR

Charles Goodwin

Zara McKinlay

+44 (0)20 3004 9512

 

About Ananda Developments

Ananda is an AQSE-listed life sciences company focused on the research and clinical development of CBD-based therapies for a range of complex inflammatory pain conditions

For further information on the Company visit https://anandadevelopments.com/ or sign up at https://investors.anandadevelopments.com/s/a66906.

https://investors.anandadevelopments.com/link/pegp0r

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NEXQKOBPBBKDFCB
Ananda Developments (AQSE:ANA)
Historical Stock Chart
From Nov 2024 to Dec 2024 Click Here for more Ananda Developments Charts.
Ananda Developments (AQSE:ANA)
Historical Stock Chart
From Dec 2023 to Dec 2024 Click Here for more Ananda Developments Charts.